X0306 4 2016-01-08 0001053691 RestorGenex Corp RESX 0001174452 LEVIN ALAN G 2020 AVON COURT, SUITE 4 CHARLOTTESVILLE VA 22902 1 Common Stock 2016-01-08 4 A 0 248032 A 248032 D Stock Option (Right to Buy) 0.42 2016-01-08 4 A 0 276140 0 A 2025-06-15 Common Stock 276140 276140 D Stock Option (Right to Buy) 0.55 2016-01-08 4 A 0 365265 0 A 2025-10-30 Common Stock 365265 365265 D 184,093 of the shares are shares of restricted common stock which vest in equal parts each month until fully vested on the third anniversary of the original grant date, June 15, 2015. Received in exchange for 67,905 units of Diffusion Pharmaceuticals LLC ("Diffusion") in connection with the consummation of the merger (the "Merger") of Diffusion and a wholly-owned subsidiary of the Issuer ("Merger Sub") on January 8, 2016 based upon the exchange rate set forth in the Agreement and Plan of Merger, dated December 15, 2015, by and among the Issuer, Diffusion and Merger Sub. In connection with the consummation of the Merger, an option originally granted on June 15, 2015 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer. The shares underlying the options vest in equal parts each month until fully vested on the third anniversary of the grant date. In connection with the consummation of the Merger, an option originally granted on October 30, 2015 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer. /s/ Ben Shealy, attorney-in-fact for Alan Levin 2016-01-12